Evidence map›Paper›PMID 38997261›Full record

ArticleBlood cancer journal2024

Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia.

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu-Hung WangDivision of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.ORCID 0000-0003-4483-5627
Chien-Chin LinDivision of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
Kristian GurashiDivision of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.
Chi-Yuan YaoDivision of Hematology, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0001-5052-9445
Andres JerezHaematology Department, Hospital Morales Meseguer, Murcia, Spain.
Hsin-An HouDivision of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
Wen-Chien ChouDivision of Hematology, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0003-2967-698X
Hwei-Fang TienDivision of Hematology, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0002-1384-5593
Kiran BattaDivision of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK. kiran.batta@manchester.ac.uk.ORCID 0000-0002-3494-0979
Daniel H WisemanDivision of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK. daniel.wiseman@manchester.ac.uk.ORCID 0000-0003-0715-1402

Funding

Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan) MOHW109-TDU-B-211-134009Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 109-2314-B-002-221Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 109-2314-B-002-222Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 111-2314-B-002-280
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myelomonocytic, ChronicTumor Suppressor Protein p53AgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID38997261
PMCPMC11245466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.